Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEARL: PErsonalized Addition of Recombinant LH in Suboptimal Responders >35 Years Old
NCT04719000Phase 4Recruiting
- Sponsor
- Fundació Santiago Dexeus Font
- Start
- Feb 2021
- Primary completion
- Aug 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of lutropin alfa in infertility (2 arms), sponsored by Fundació Santiago Dexeus Font. Primary endpoints: Serum progesterone levels on the day of ovulation triggering and Progesterone/Estrogen ratio. Started Feb 2021; status: recruiting.
02
Drugs
lutropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on NCT04719000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04719000.